Sign Out
Sanacore is intended for use by physicians familiar with the product in a hospital setting with monitoring and cardio-respiratory resuscitation equipment available for immediate use if necessary.
The occurrence of angina, severe bradycardia, severe hypotension, respiratory failure (potentially fatal), or asystole/cardiac arrest (potentially fatal), should lead to immediate discontinuation of administration.
In patients with history of convulsions/seizures, the administration of adenosine should be carefully monitored.
Patients with atrial fibrillation/flutter and an accessory by-pass tract may develop increased conduction down the anomalous pathway.
Because of the possible risk of torsades de pointes, Sanacore should be used with caution in patients with a prolonged QT interval, whether this is congenital, drug induced or of metabolic origin.
In patients with chronic obstructive pulmonary disease, adenosine may precipitate or aggravate bronchospasm.
Effects on ability to drive and use machine: Not applicable.
Continue with Google